Baylor University

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
Mayo Clinic, Certified Management Accountant, Surgeon, CMA, Meta, University, International, International Accounting Standards Committee, Classification, Baylor College of Medicine, London Business School, Principal investigator, Clinical trial, Baylor University, Perimeter, Master, Sloan Fellows, FSE, Management science, ID, InterAction Council of Former Heads of State and Government, Baptists, Patient, International Financial Reporting Standards, Engineering, OCT, OTC, Webcast, CFO, Association of British HealthTech Industries, IAS, FDA, PINK, Medtech, International Accounting Standards Board, Management, Medical device, Cryptocurrency, DALLAS, Science

TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, Aug. 29, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.
  • In addition, I am pleased to report that Sara Brien will become Perimeter's Chief Financial Officer, effective September 1, 2023.
  • The study is evaluating the use of Perimeter B-Series OCT combined with its proprietary ImgAssist AI software during breast conservation surgery.
  • The Company will host a conference call and live audio webcast today, Tuesday, August 29, 2023, at 5:00 pm Eastern Time to discuss its second quarter 2023 results and to provide a corporate update.

Valify Announces Executive Appointments

Retrieved on: 
Monday, August 28, 2023
Technology, Managed Care, Electronic Commerce, General Health, Hospitals, Nursing, Payments, Medical Supplies, Health, Health Technology, Other Technology, Software, Other Health, Networks, Mobile, Wireless, Data Management, Practice Management, University, College, Information technology, Classification, Western Governors University, College of Healthcare Information Management Executives, MBA, Multimedia, BBA, Baylor University, CHIME, CFO, Growth, Benchmarking, HCA Healthcare, Management information system, Sarah Cannon Research Institute, Management

View the full release here: https://www.businesswire.com/news/home/20230828685746/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230828685746/en/
    Jessica Burns assumes the role of Chief Operating Officer for Valify and Valify Solutions Group, an innovative group purchasing model tailored exclusively to hospital purchased services.
  • Drawing upon an extensive background in business operations, strategic alignment, technology and portfolio expansion, Ms. Burns will concentrate on creating and optimizing processes for Valify as it continues to scale for growth.
  • A co-founder of Valify, Clark served as CTO and CFO from 2014 to 2019 and played a pivotal role in the inception, design and development of Valify products.
  • Les Popiolek, CEO of Valify, underscored the organization's commitment to help providers in light of the current inflationary landscape.

Krispy Kreme Announces Stephanie Daukus as Vice President of Investor Relations

Retrieved on: 
Monday, August 28, 2023
Retail, Restaurant, Bar, Food, Beverage, Communication, University, University of Illinois Chicago, Krispy Kreme, Chicago, Baylor University, Management, Cream

Krispy Kreme, Inc. (NASDAQ:DNUT), today announced that Stephanie Daukus will join the company as Vice President of Investor Relations effective today.

Key Points: 
  • Krispy Kreme, Inc. (NASDAQ:DNUT), today announced that Stephanie Daukus will join the company as Vice President of Investor Relations effective today.
  • In this role, Stephanie will be responsible for leading the company’s investor relations practices, including the communication of the company’s financial performance and corporate strategy to the investment community and serving as the primary point of contact for analysts and investors.
  • She will report to Jeremiah Ashukian, Executive Vice President and Chief Financial Officer.
  • “We are thrilled to have Stephanie join the Krispy Kreme team.

Pacific Dermatology Specialists Announces New Fullerton, CA Location

Retrieved on: 
Friday, August 25, 2023
Salma, Society, Evidence-based medicine, Skin care, PPO, HMO, Dermatology, Baylor University, Multimedia, Human, Medicare, Suite, Patient, Baylor College of Medicine, UCLA, Nursing, Science

FULLERTON, Calif., August 25th, 2023 /PRNewswire-PRWeb/ -- Pacific Dermatology Specialists is proud to announce the opening of our newest location in Fullerton, CA.

Key Points: 
  • Pacific Dermatology Specialists is proud to announce the opening of our newest location in Fullerton, CA.
  • The practice offers a range of skin care services, including medical and pediatric dermatology.
  • FULLERTON, Calif., August 25th, 2023 /PRNewswire-PRWeb/ -- Pacific Dermatology Specialists is proud to announce the opening of our newest location in Fullerton, CA.
  • At Pacific Dermatology Specialists, they understand that receiving timely care is important, which is why they offer same-day and next-day appointments.

The Inner Circle Acknowledges, Joey Kevin Grochmal as a Pinnacle Life Member for his contributions to the Medical and Educational Fields

Retrieved on: 
Monday, August 21, 2023
Faculty, Royal college, University, Education, Health, Tetraplegia, Baylor College of Medicine, Stroke, Neoplasm, Medical college, Physician, Spinal cord, Infection, University of Alberta Faculty of Medicine and Dentistry, Baylor University, Spine, Head, Rehabilitation, Brain, Mentorship, Multimedia, Sympathetic nervous system, Disorder, Assistant, Inner circle, Science, SUNY Downstate Health Sciences University, Congress of Neurological Surgeons, Royal College of Physicians and Surgeons of Canada, American Association of Neurological Surgeons, Master of Science, Nervous system, Medical College of Wisconsin, Surgeon, Diagnosis, Knowledge, Society, Nursing, Dentistry, Medicine, Neuroscience, MD, Neurosurgery

HOUSTON, Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joey Kevin Grochmal is acknowledged as a Pinnacle Life Member for his contributions to the Medical and Educational Fields.

Key Points: 
  • HOUSTON, Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joey Kevin Grochmal is acknowledged as a Pinnacle Life Member for his contributions to the Medical and Educational Fields.
  • Dr. Grochmal pursued higher education at the University of Alberta in Canada where he received a Bachelor of Science degree in Neuroscience.
  • The doctor capped his scholarship by finishing a fellowship in spine surgery at the Medical College of Wisconsin in 2018.
  • Dr. Grochmal is a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPSC).

McGovern Allergy & Asthma Clinic Welcomes Dr. An Nguyen to Their Team of Houston Allergists!

Retrieved on: 
Thursday, August 10, 2023
University of Texas Southwestern Medical Center, Travel, Education, Dermatitis, Baylor University, Texas Medical Association, Immunomodulation, American Academy, Research, Fungus, Affection, Allergist, Patient, Internal medicine, Immune system, American Academy of Allergy, Asthma, and Immunology, Motivation, Baylor College of Medicine, Knowledge, Vitamin D, Immunology, American College, Health, Family, Nursing, Medical device, Cochineal, Nguyen, Allergy, Asthma

HOUSTON, Aug. 10, 2023 /PRNewswire-PRWeb/ -- Dr. An Nguyen is making significant strides in Allergy and Immunology with her extensive educational background and dedication to providing comprehensive and personalized treatment to individuals of all ages. Dr. Nguyen obtained her doctorate from UT Southwestern and further specialized in Internal Medicine during her Baylor College of Medicine residency. Her relentless pursuit of knowledge led her to complete a fellowship in Allergy and Immunology at the same prestigious institution. During her fellowship, Dr. Nguyen focused on groundbreaking research, investigating the role of vitamin D in the immunomodulation of allergic disease and the impact of fungi on sinus disease and asthma. Inspired by her experience with allergies and eczema, Dr. Nguyen chose to specialize in Allergy and Immunology. She believes that her journey enables her to empathize with patients on a deeper level while providing invaluable education to empower them to manage their conditions effectively.

Key Points: 
  • Dr. An Nguyen, a highly accomplished and compassionate medical professional, joins the McGovern Allergy & Asthma Clinic team.
  • Dr. Nguyen obtained her doctorate from UT Southwestern and further specialized in Internal Medicine during her Baylor College of Medicine residency.
  • Her relentless pursuit of knowledge led her to complete a fellowship in Allergy and Immunology at the same prestigious institution.
  • Dr. Nguyen emphasizes the importance of seeking specialized care from an allergy specialist to address allergy and asthma symptoms.

Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform

Retrieved on: 
Tuesday, August 8, 2023
Genetic variation, Biobank, UK Biobank, Molecule, Workflow, HT, NGS, Baylor University, Proteomics, Human genetics, Genetics, Protein, BCM, HGSC, Baylor College of Medicine, Gene, Multiomics, Disease, Medicine

UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has selected the Olink Explore platform as a proteomics component of their world-class multiomics offering.

Key Points: 
  • UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has selected the Olink Explore platform as a proteomics component of their world-class multiomics offering.
  • “We are immensely pleased to see the Olink Explore HT platform implemented at one of the world’s leading multiomic research centers,“ said Jon Heimer, CEO, Olink Proteomics.
  • “Technology development and the adoption of new methods remains a priority at the HGSC, and we are excited to incorporate Olink’s technology into our portfolio,” said Richard Gibbs, Ph.D. Director, Human Genome Sequencing Center and Wofford Cain Professor of Molecular & Human Genetics, Baylor College of Medicine.
  • Olink Explore HT is the company's latest solution for high-throughput proteomics, delivering unmatched specificity, scalability, and simplicity.

Texas Children's Pavilion for Women Announces Opening of New Medical Tower

Retrieved on: 
Monday, August 7, 2023
News, Skyway, Obstetrics, Life, Pavilion of Women, Partner, Baylor University, Infertility, Women's Service Guilds, Assistant, U.S. News & World Report, Physical therapy, Memorial Hermann–Texas Medical Center, Hospital, Patient, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Menopause, Gynaecology, Texas Medical Center, Baylor College of Medicine, Growth, Health, Birth control, Pavilion, Woman, Texas Children's Hospital

HOUSTON, Aug. 7, 2023 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that the newest medical tower, Pavilion for Women Tower II, has opened for patient activity. As the second phase of the $245 million Texas Children's Pavilion for Women's expansion within the Texas Medical Center nears completion, the new tower connected to the Pavilion for Women via a recently constructed sky bridge houses women's services outpatient clinics, including The Women's Specialists of Houston, Partners in OB/GYN Care, and Women's Physical Therapy.

Key Points: 
  • HOUSTON, Aug. 7, 2023 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that the newest medical tower, Pavilion for Women Tower II, has opened for patient activity.
  • Since opening its doors over a decade ago, the Pavilion for Women has seen rapid growth in the volume of patients seeking labor and delivery services, and the next step of this expansion includes increasing the number of hospital beds in the Texas Children's Pavilion for Women.
  • "I am so proud of everything we've done together and I'm beyond grateful and excited for the continuous growth of Texas Children's Pavilion for Women."
  • Texas Children's is consistently ranked among the best children's hospitals nationally by U.S. News & World Report, and first in Texas.

Marker Therapeutics Reports Non-Clinical Proof-of-Concept Data and Update on Clinical Readiness for the MT-401 Off-the-Shelf Program

Retrieved on: 
Monday, August 7, 2023
Immortalised cell line, Graft-versus-host disease, Marker, OTS, GVHD, Blood, HLA, Leukemia, Allele, Baylor University, HSCT, Assistant, THP-1 cell line, Development, AML, Patient, Risk, Baylor College of Medicine, VST, FDA, Therapy, Biomedical Advanced Research and Development Authority, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Bone marrow, Vaccine, Medical imaging, Pharmaceutical industry, Medical device, Research

Leukemic cell growth was significantly reduced when treated with MT-401 OTS.

Key Points: 
  • Leukemic cell growth was significantly reduced when treated with MT-401 OTS.
  • Marker has established a cellular inventory of 8 lines manufactured from healthy donors, with ongoing efforts to further expand the inventory.
  • Marker anticipates that the first patient will be treated with MT-401 OTS during the first half of 2024.
  • If MT-401 OTS is successful in clinical trials, we will consider expanding the OTS multiTAA-specific T cell program to other indications with unmet medical needs,” concluded Dr. Vera.

Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy

Retrieved on: 
Thursday, August 3, 2023
San Francisco, Doctor of Public Health, Mayo Clinic, University, University of Minnesota, Icahn School of Medicine at Mount Sinai, Neoplasm, University of Washington, Cohort (statistics), New York University Grossman School of Medicine, University of California, San Francisco, Baylor University, National Cancer Institute, Toxicity, MBA, Research, Mount Sinai, Doctor of Philosophy, University of Miami, Proteomics, MS, Amanda Paulovich, MD Anderson Cancer Center, University of Michigan School of Kinesiology, Death, Protein, Michigan Medicine, Patient, James D. Watson Institute of Genome Sciences, Baylor College of Medicine, University of Arkansas, Mortality, Trial of the century, Fred Hutchinson Cancer Research Center, Ovarian cancer, Dana–Farber Cancer Institute, Vaccine, Pharmaceutical industry, Medical imaging, Management, Genetics, MD, Cell, Medicine

NEW YORK, Aug. 3, 2023 /PRNewswire-PRWeb/ -- Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy.

Key Points: 
  • The multicenter study, published online August 3 in Cell, reports on a pioneering analysis of chemo-refractoriness in high-grade serous ovarian cancer (HGSOC).
  • The multicenter study, published online August 3 in Cell [DOI#: 10.1016/j.cell.2023.07.004], reports on a pioneering analysis of chemo-refractoriness in high-grade serous ovarian cancer (HGSOC).
  • Currently, there's no way to distinguish refractory cases (who never respond to chemotherapy), leading some patients to unnecessarily experience the adverse effects of platinum-based chemotherapy without the benefits.
  • The investigators studied 242 tumors samples collected from HGSOC patients comprising both chemo-refractory and chemo-responsive individuals before they received chemotherapy.